In an interview with former BlackRock advisor Edward Dowd on “RFK Jr. The Defender Podcast,” Robert F. Kennedy, Jr. and Dowd discussed the financial and moral implications of fraudulent data from the COVID-19 vaccine trials.

Dowd, a managing director with BlackRock from 2002 to 2012, said, “what tipped me off to the fraud” was when the U.S. Food and Drug Administration (FDA) announced it wouldn’t release the trial data for 75 years. He knew something wasn’t right.

Dowd told Kennedy:

“The FDA is in on the cover-up, something went down. The other tip for me was in November of last year, a friend of mine from the biotech industry discovered that Pfizer had failed their all-cause mortality endpoint. And that was not available to us when this fanfare occurred in November of 2020, when they all got excited about 95% efficacy.”

Dowd concluded, “the FDA didn’t really look at this clinical trial data” yet rushed it through due to political pressure or “maybe straight-up bribes,” but either way, he said, the vaccines should have never been approved.